Guanfacine Tablet, Extended Release
Product Images NDC 0228-2850

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 0228-2850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Following Chemical Structure Of Guanfacine Hydrochloride, Usp Is A White To Off-white Crystalline Powder, Sparingly Soluble In Water (approximately 1 mg/ml) And Alcohol And Slightly Soluble In Acetone. The Only Organic Solvent In Which It Has Relatively High Solubility Is Methanol (greater Than 30 mg/ml). Each Tablet Contains Guanfacine Hydrochloride, Usp Equivalent To 1 mg, 2 mg, 3 mg, Or 4 mg Of Guanfacine Base. (Image 1)

The Following Chemical Structure Of Guanfacine Hydrochloride, Usp Is A White To Off-white Crystalline Powder, Sparingly Soluble In Water (approximately 1 mg/ml) And Alcohol And Slightly Soluble In Acetone. The Only Organic Solvent In Which It Has Relatively High Solubility Is Methanol (greater Than 30 mg/ml). Each Tablet Contains Guanfacine Hydrochloride, Usp Equivalent To 1 mg, 2 mg, 3 mg, Or 4 mg Of Guanfacine Base. (Image 1)
FDA Label Image

1 (Image 10)

1 (Image 10)
This is a medication label for Guanfacine extended-release tablets, with a dosage instruction to not crush or chew the tablet before swallowing. The label has a product code of NDC0226-2850-11 and is manufactured by Actavis in the USA. The exact dosage is not mentioned, and the label advises referring to an accompanying product.*
FDA Label Image

2 (Image 11)

2 (Image 11)
This is a prescription drug information label that provides details on the medication Guanfacine, which comes in the form of extended-release tablets. The label warns against crushing, chewing or breaking the tablets before swallowing. The drug is distributed by Actavis and requires a prescription to obtain.*
FDA Label Image

3 (Image 12)

3 (Image 12)
This is a description of a medication called "Guanfacine f—Extended-Release Tablets". The medication comes in a bottle with 100 tablets, and should not be crushed or chewed before swallowing. The bottle contains instructions to dispense the medication separately for each patient. There are several numbers and codes listed on the bottle, including the drug identification number (NOC 0228-2853-11) and a phone number for customer service inquiries. Additionally, there is information about the active ingredients of the medication, which include Goiacng oo and Smg Gooscine b. The description also indicates that the medication is only available with a prescription from a licensed pharmacist or doctor.*
FDA Label Image

4 (Image 13)

4 (Image 13)
FDA Label Image

Correct-figure (Image 2)

Correct-figure (Image 2)
The text describes a graph showing the plasma concentration of Guanfacine over time. The graph shows the concentrations of both Guanfacine Extended-Release and Immediate-Release Guanfacine at a dose of 1mg once a day.*
FDA Label Image

Figure 2: Effect Of Other Drugs On The Pharmacokinetics (pk) Of Guanfacine Extended-release (Image 3)

Figure 2: Effect Of Other Drugs On The Pharmacokinetics (pk) Of Guanfacine Extended-release (Image 3)
FDA Label Image

Figure 3: Effect Of Guanfacine Extended-release On The Pharmacokinetics (pk) Of Other Drugs (Image 4)

Figure 3: Effect Of Guanfacine Extended-release On The Pharmacokinetics (pk) Of Other Drugs (Image 4)
FDA Label Image

Figure 4 (Image 5)

Figure 4 (Image 5)
FDA Label Image

Round Tablet Debossed (Image 6)

Round Tablet Debossed (Image 6)
FDA Label Image

Round Tablet Debossed (Image 7)

Round Tablet Debossed (Image 7)
FDA Label Image

Round Tablet Debossed (Image 8)

Round Tablet Debossed (Image 8)
FDA Label Image

Round Tablet Debossed (Image 9)

Round Tablet Debossed (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.